单形性嗜上皮性肠T细胞淋巴瘤的非典型临床病理特征
回顾性分析36例单形性嗜上皮性肠T细胞淋巴瘤(MEITL)病例,中位年龄57岁,22例(61%)出现肠外病灶,34例死亡,中位生存期6个月。9例(25%)呈显著多形性,P53和c-Myc高表达与非典型形态相关,高表达P53组生存期短于低表达P53组。
要点
- MEITL罕见且高度侵袭,本组36例中34例死亡,中位生存期6个月。
- 9例(25%)肿瘤细胞呈显著多形性而非经典单形性外观。
- 高表达P53组生存期短于低表达P53组(χ²=4.922,P=0.027)。
核心结论
- MEITL是一种罕见的高度侵袭性淋巴瘤,部分病例可表现出非典型的临床及病理特征,提高对这类疾病的认识有助于早期正确诊断及新治疗方案的确立。
研究设计与样本
- 纳入2015年6月至2024年1月苏州大学附属第四医院和浙江大学医学院附属第一医院的MEITL病例共36例,进行免疫组化、EBER原位杂交和T细胞受体重排检测,收集临床、实验室检查及随访资料进行相关性研究。
主要发现
- 36例患者中男20例、女16例,中位年龄57(17~76)岁;22例(61%)出现肠道以外的病灶;32例(89%)接受手术和(或)化疗,1例接受auto-HSCT。
- 中位随访时间11.5(8~73)个月,34例(94%)死亡,中位生存期6(1~67)个月。
- 组织形态学显示9例(25%)肿瘤细胞表现出显著的多形性而非经典的单形性外观;P53和c-Myc高表达均与非典型组织形态学相关(P=0.003;P=0.016)。
- 高表达P53组的生存期短于低表达P53组(χ²=4.922,P=0.027),c-Myc表达水平对生存期无影响(χ²=0.034,P=0.854)。
- 22例(68.8%)PD-L1联合阳性分数评分≥10分;4例(11%)背景淋巴细胞EBER阳性;17例(17/17,100.0%)检测到克隆性TCR基因重排。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study sought to examine the clinicopathological features of monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) and to discuss its differential diagnosis. Methods: A total of 36 MEITL cases, collected between June 2015 and January 2024 from the Fourth Affiliated Hospital of Soochow University and the First Affiliated Hospital, College of Medicine, Zhejiang University, were analyzed. Patients underwent immunohistochemistry, in situ hybridization for Epstein-Barr virus-encoded small RNA (EBER), and T-cell receptor (TCR) gene rearrangement testing. Clinical data, laboratory results, and follow-up information were collected for correlation analysis. Results: The cohort included 36 patients (20 males and 16 females) aged 17-76 years (median: 57 years). Tumors outside the intestine were observed in 22 cases (61%). A total of 32 patients (89%) underwent surgical intervention and/or chemotherapy, and one patient received auto-HSCT. The median follow-up duration was 11.5 months (range: 8-73 months), with a median overall survival of 6 months (range: 1-67 months) ; 34 patients died during the follow-up period. Morphologically, nine cases (25%) exhibited significant pleomorphism. Immunohistochemical analysis revealed that high expression levels of both P53 and c-Myc were correlated with atypical morphology (P=0.003 and P=0.016, respectively). Notably, patients with high P53 expression had significantly shorter survival times than those with low P53 expression (χ(2)=4.922, P=0.027), whereas survival did not differ significantly based on c-Myc expression levels (χ(2)=0.034, P=0.854). Furthermore, a PD-L1 CPS score ≥10 was observed in 22 cases (68.8%). Scattered EBER positivity in background cells was identified in four cases. All tested cases (17/17, 100.0%) showed clonal TCR gene rearrangements. Conclusions: MEITL is a rare but highly aggressive lymphoma with distinct clinical and pathological features. A subset of cases may exhibit atypical morphological patterns, complicating the diagnostic process. Improving awareness of this neoplasm is helpful for early and precise diagnosis as well as the estabolishment of novel therapy regimen. 目的: 探讨单形性嗜上皮性肠T细胞淋巴瘤(MEITL)的临床病理特征并讨论其诊断与鉴别诊断。 方法: 纳入2015年6月至2024年1月期间苏州大学附属第四医院和浙江大学医学院附属第一医院的MEITL病例共36例,进行免疫组化、EB病毒编码的小RNA(EBER)原位杂交和T细胞受体重排检测,收集临床、实验室检查及随访资料并进行相关性研究。 结果: 36例患者中男20例、女16例,中位年龄57(17~76)岁。22例(61%)出现肠道以外的病灶。32例(89%)接受手术和(或)化疗,1例接受auto-HSCT。中位随访时间为11.5(8~73)个月,34例(94%)死亡,中位生存期为6(1~67)个月。组织形态学结果显示,9例(25%)肿瘤细胞表现出显著的多形性,而非经典的单形性外观。免疫组织化学染色发现,P53和c-Myc高表达均与非典型组织形态学具有相关性(P=0.003;P=0.016)。高表达P53组的生存期短于低表达P53组(χ (2)=4.922,P=0.027),而c-Myc的表达水平对生存期无影响(χ (2)=0.034,P=0.854)。22例(68.8%)PD-L1联合阳性分数评分≥10分。EBER原位杂交检测显示,4例(11%)背景淋巴细胞呈阳性表达。17例(17/17,100.0%)检测到克隆性TCR基因重排。 结论: MEITL是一种罕见的高度侵袭性淋巴瘤,部分病例可表现出非典型的临床及病理特征,提高对这类疾病的认识,有助于早期正确诊断及新治疗方案的确立。.
引用
- Xiong DT, Cheng F, Xu JZ, et al. [Atypical clinicopathological features of monomorphic epitheliotropic intestinal T-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40887421. doi:10.3760/cma.j.cn121090-20241120-00459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。